43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology 2025

The 43rd edition of the Vicenza Course will focus on new developments in the areas of technology, pharmacology, clinical trials and consensus definitions in critical care nephrology. The scope of the course will be to offer the most updated information on scientific advances and breakthrough technologies, together with basic concepts and practical hands-on instructions for beginners and advanced users. The final intent is to improve knowledge and skills in the area of Acute Kidney Injury and related diagnostic procedures and therapeutic strategies including new pharmacological options and new extracorporeal therapies. Special focus will be placed on pharmacological approaches to manage AKI and the transition from AKI to AKD and CKD. Avoiding or slowing progression to CKD is one of the main objectives of new pharmacological therapies and the course will highlight the important contribution of drugs. This is a true course and not a simple congress or meeting. We will maintain the structure that over the years has demonstrated to be useful for the audience and excellent in facilitating contacts among specialists and experts of the field. The structure of the program will consist in a series of sessions designed to enable the attendees to explore in depth the topics where new evidence exists.  The scientific program will be integrated by industry sponsored symposia including new technologies and new pharmacological trends in AKI-AKD-CKD, meet the expert sessions and short presentations in the traditional space dedicated to the industry-academic alliance. Topics related to the multidisciplinary field of critical care nephrology will represent the main content of the course: AKI in different pathological conditions, diagnosis, pathophysiology, prevention and therapeutic strategies; biomarkers and other diagnostic techniques;  Sepsis and related mechanisms including viral, bacterial and other infections; indications and timing for RRT, modalities of RRT, dose and prescription, membranes and sorbents, outcome measures, information communication technology related to healthcare and critical care nephrology, results of the nomenclature and other consensus conferences proposed by ADQI and many other topics. In particular, we will focus on end points for new clinical trials with particular attention to pharmacological interventions in the post AKI phase and the AKD to CKD progression. Last but not least, we will focus this year on healthcare disparities, gender-related issues and green medicine with special attention to sustainable and environment-friendly therapies. The participation to this event will be, as in the past, an unforgettable experience and an exceptional occasion to meet your favorite opinion leaders in the field of critical care nephrology.